Spyre Therapeutics (SYRE) Enterprise Value Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168.10% |
| Dec 31, 2025 | -138.58% |
| Sep 30, 2025 | -87.57% |
| Jun 30, 2025 | -81.17% |
| Mar 31, 2025 | -103.60% |
| Dec 31, 2024 | -86.22% |
| Sep 30, 2024 | -54.24% |
| Jun 30, 2024 | -49.08% |
| Mar 31, 2024 | -56.41% |
| Dec 31, 2023 | -32.37% |
| Sep 30, 2023 | -13.30% |
| Jun 30, 2023 | -14.27% |
| Mar 31, 2023 | 7.74% |
| Dec 31, 2022 | 8.17% |
| Sep 30, 2022 | 6.00% |
| Jun 30, 2022 | 5.68% |
| Mar 31, 2022 | -0.92% |
| Dec 31, 2021 | -7.72% |
| Sep 30, 2021 | -21.29% |
| Jun 30, 2021 | -21.22% |
| Mar 31, 2021 | -46.44% |
| Dec 31, 2020 | -42.74% |
| Sep 30, 2020 | -37.54% |
| Jun 30, 2020 | -35.51% |
| Mar 31, 2020 | 5.40% |
| Dec 31, 2019 | -4.25% |
| Sep 30, 2019 | -9.24% |
| Jun 30, 2019 | -12.78% |
| Mar 31, 2019 | -30.83% |
| Dec 31, 2018 | -31.11% |
| Sep 30, 2018 | -26.89% |
| Jun 30, 2018 | -22.70% |
| Mar 31, 2018 | 2.70% |